Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
Discovery on TargetDiscovery on Target
Not Confirmed
Not Confirmed
30 September-03 October, 2024
Not Confirmed
Not Confirmed
30 September-02 October, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
Discovery on TargetDiscovery on Target
Industry Trade Show
Not Confirmed
30 September-03 October, 2024
Industry Trade Show
Not Confirmed
30 September-02 October, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices
09 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/compugen-to-present-at-single-cell-genomics-2024-conference-302241834.html
29 Aug 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/compugen-to-present-at-the-hc-wainwright-26th-annual-global-investment-conference-302233882.html
06 Aug 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/compugen-reports-second-quarter-2024-results-302215329.html
17 Jun 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/compugen-to-present-at-upcoming-antibody-industrial-symposium-302174100.html
30 May 2024
// ENDPTS
https://endpts.com/compugen-nxera-disclose-milestone-payments-insmed-aims-for-650m-offering/
30 May 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/compugen-to-receive-milestone-payment-triggered-by-dosing-of-first-patient-in-the-second-phase-3-trial-evaluating-rilvegostomig-302159115.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?